A study of heat shock protein 27 in endometrial carcinoma

被引:45
作者
Geisler, JP [1 ]
Geisler, HE
Tammela, J
Miller, GA
Wiemann, MC
Zhou, Z
机构
[1] St Vincents Hosp & Hlth Syst, Div Gynecol Oncol, Dept Obstet & Gynecol, Indianapolis, IN 46260 USA
[2] St Vincents Hosp & Hlth Syst, Div Oncol Res, Dept Med, Indianapolis, IN 46260 USA
[3] Lab Diagnost & Analyt Cytometry, Dept Pathol, Indianapolis, IN 46268 USA
关键词
endometrial cancer; heat shock protein 27; HSP27;
D O I
10.1006/gyno.1998.5283
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Heat shock protein 27 (HSP27) is a relatively small protein produced in response to pathophysiologic stress. The purpose of this study was to determine prospectively whether HSP27 was associated with known prognostic factors in patients with endometrial carcinoma. Methods. One hundred fifty-three consecutive patients with endometrial carcinoma were studied. Slides were prepared from fresh tissue. HSP27 was analyzed using a semiquantitative measurement. Patient records were examined for FIGO stage, grade, depth of myometrial invasion, histology, lymphovascular space invasion, time to recurrence, and survival. Results. The mean follow-up was 53 months (median 56 months, range 30-68 months). Endometrioid tumors showed significantly higher HSP27 staining than nonendometrioid tumors (P = 0.005). Patients alive at the conclusion of this study had significantly higher mean HSP27 staining than patients who were deceased (P < 0.001), Logistic regression revealed HSP27 staining (P = 0.02), FIGO stage (P = 0.014), and lymphovascular space invasion (P = 0.046) to be independently predictive of survival. Conclusion. HSP27 staining is significantly higher in endometrioid than nonendometrioid tumors. HSP27 staining is an independent prognostic indicator in patients with endometrial carcinoma, the most common gynecologic malignancy in the United States. (C) 1999 Academic Press.
引用
收藏
页码:347 / 350
页数:4
相关论文
共 23 条
[1]  
ADAMS DJ, 1985, CANCER RES, V45, P2445
[2]  
Announcements, 1989, Gynecologic Oncology, V35, P125, DOI [DOI 10.1016/0090-8258(89)90027-9, 10.1016/0090-8258(89)90027-9]
[3]  
CANO A, 1986, CANCER RES, V46, P6475
[4]  
CIOCCA DR, 1989, CANCER RES, V49, P4298
[5]   COLOCALIZATION OF ESTROGEN AND PROGESTERONE RECEPTORS WITH AN ESTROGEN-REGULATED HEAT-SHOCK PROTEIN IN PARAFFIN SECTIONS OF HUMAN BREAST AND ENDOMETRIAL CANCER-TISSUE [J].
CIOCCA, DR ;
STATI, AO ;
DECASTRO, MMA .
BREAST CANCER RESEARCH AND TREATMENT, 1990, 16 (03) :243-251
[6]   LOCALIZATION OF AN ESTROGEN-RESPONSIVE PROTEIN IN THE HUMAN CERVIX DURING MENSTRUAL-CYCLE, PREGNANCY, AND MENOPAUSE AND IN ABNORMAL CERVICAL EPITHELIA WITHOUT ATYPIA [J].
CIOCCA, DR ;
PUY, LA ;
LOCASTRO, G .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 155 (05) :1090-1096
[7]  
CIOCCA DR, 1992, CANCER RES, V52, P3648
[8]   BIOLOGICAL AND CLINICAL IMPLICATIONS OF HEAT-SHOCK PROTEIN 27000 (HSP27) - A REVIEW [J].
CIOCCA, DR ;
OESTERREICH, S ;
CHAMNESS, GC ;
MCGUIRE, WL ;
FUQUA, SAW .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (19) :1558-1570
[9]   THE PRESENCE OF AN ESTROGEN-REGULATED PROTEIN DETECTED BY MONOCLONAL-ANTIBODY IN ABNORMAL HUMAN-ENDOMETRIUM [J].
CIOCCA, DR ;
PUY, LA ;
EDWARDS, DP ;
ADAMS, DJ ;
MCGUIRE, WL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (01) :137-143
[10]  
CIOCCA DR, 1983, J CLIN ENDOCR METAB, V57, P496, DOI 10.1210/jcem-57-3-496